Table 2 Number of studies evaluating each factor assessed for disparity by outcome in the US and non-US studies.
From: Global disparities in patients with multiple myeloma: a rapid evidence assessment
Factors assessed for disparity | Outcome | |||||||
|---|---|---|---|---|---|---|---|---|
Diagnosis | Access to treatment | Survival | Mortality | |||||
US | Non-US | US | Non-US | US | Non-US | US | Non-US | |
Total number of studies | 2 | 4 | 24 | 11 | 27 | 21 | 13 | 16 |
Age | 0 | 1 | 15 | 6 | 24 | 14 | 3 | 11 |
Sex | 1 | 0 | 12 | 2 | 19 | 14 | 6 | 10 |
Race/ethnicity | 2 | 0 | 19 | 2 | 24 | 4 | 11 | 1 |
Socioeconomic status | 0 | 3 | 12 | 7 | 11 | 8 | 3 | 6 |
Geography | 0 | 1 | 5 | 2 | 4 | 5 | 2 | 5 |
